Latest Articles

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Findings from a multicentre prospective Artemis study.

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Major GI Bleeding in VTE RIETE Analysis

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.

Global use of RAM and Thromboprophylaxis in hospitalized patients

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.

Evaluation Of Comparative Efficacy and Safety of Thromboprophylaxis Agents Among Critically Ill Patients

This systematic review and network meta-analysis revealed that the use of low-molecular-weight heparin (LMWH) may be more effective than unfractionated heparin (UFH) in reducing incidence of deep vein thrombosis (DVT) among critically ill patients.